Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks consistent with how only the "Best Penny Stocks" perform in the penny stock market, we have to keep our penny stock picks producing large and consistent gains.Have a look at today’s active stocks: Vical Incorporated(NASDAQ:VICL), Spirit Realty Capital, Inc.(NYSE:SRC), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX)
Vical Incorporated(NASDAQ:VICL) reported the gain of 10.37% and closed at $1.49 with the total traded volume of 5.55M shares. Its market capitalization is $129.20 million. The stock has a 52-week high price of $4.51 and its 52-week low was recorded at $1.17
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
What VICL Charts Are Signaling for Traders? Find Out Here
Spirit Realty Capital, Inc.(NYSE:SRC) gain 3.43% and ended at $9.94.The total traded volume was 20.33M shares and market capitalization arrived at $3.56 billion. The stock has a 52-week high price of $23.06 and its 52-week low was recorded at $8.24, while during last trade its minimum price was $9.77 and it gained the highest price of $9.99.
Spirit Realty Capital, Inc is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing, commercial real estate facilities where tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits.
Is SRC Buy After The Recent Price Movement? Find Out Here
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA)’s reported loss -6.13% and close at $3.06 with the overall traded volume of 10.56M shares. Its market capitalization on last close reached to $566.43M. The company has the total of 185.11M outstanding shares. Its intraday-low price was $3.01 and its hit its day's highest price at $3.24.
ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chroni
Should ARIA a Buy or Sell Now? Find Out Here
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) gain 10.44% and settle at $2.01. Its total traded volume during last trading session was 5.26M shares. The overall market worth of this company is about $106.32M. The 52 week range of the stock remained $0.37 - $3.65, while its day's lowest price was $1.86 and its hit its day's highest price at $2.10.
Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
What CPRX Charts Are Signaling for Traders? Find Out Here
Penny stocks are stocks that can be traded in the stock market at a very cheap price. The investor who decides to buy penny stocks should have a substantial intellect of the market and should be bequeathing to possibly suffer a loss in money. The phrase penny stock is usually used for stock dealing that does not imply the greater and popularly known exchanges.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the PennyStockParlay.comnewsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
PennyStockParlay.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your investment manager before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies in the profiled on the PennyStockParlay.com web site and/or newsletter involve a high degree of risk and volatility, and all investors should know that they may lose a portion or all of their investment if they decide to purchase any stock.
Read Full Disclaimer at: http://pennystockparlay.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)